English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
Mark Holland, Ph.D.
Dr. Holland is a statistician by training and serves as the Director—Bioinformatics/Biostatistics for Chemistry Research and Development. He has extensive experience in the development and application of biostatistical methods for in-vitro diagnostic assay development, including analytical and clinical performance evaluation.
Dr. Holland is a statistician by training. For the past 11 years, he has applied his extensive experience in the development and application of biostatistical methods for in-vitro diagnostic assay development, including analytical and clinical performance evaluation, at Beckman Coulter. He currently serves as the Director—Bioinformatics/Biostatistics for Chemistry Research and Development.
Dr. Holland received his Ph.D. in statistics from the University of Minnesota. For the past 11 years, he has applied his extensive experience in the development and application of biostatistical methods for in-vitro diagnostic assay development, including analytical and clinical performance evaluation, at Beckman Coulter. He currently serves as the Director—Bioinformatics/Biostatistics for Chemistry Research and Development.
Articles
Enhancing Quality in Clinical Laboratories with Six Sigma
In the fast-paced world of clinical laboratories, accuracy and precision are of utmost importance. The sigma metric has emerged as a valuable tool for assessing assay performance, comparing instruments, and optimizing quality control schemes. Learn more about the impact of Six Sigma in enhancing quality and reducing errors.
